PETER KELLEY: Open Payments
NPI 1689630725 · CORFU, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 52 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $185 |
| Novo Nordisk Inc | 10 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Insulet Corporation | 4 | $88 |
| SANOFI-AVENTIS U.S. LLC | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Cumberland Pharmaceuticals, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Corcept Therapeutics | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $30 |
Products named: MOUNJARO, Kerendia, Ozempic, Omnipod, TZIELD, REXULTI, KRISTALOSE, Auvelity.
Industry payments across NY — which companies pay providers there.
